-
1دورية أكاديمية
المؤلفون: Ruben A. G. van Eerden, Leni van Doorn, Femke M. de Man, Niels Heersche, Michail Doukas, Thierry P. P. van den Bosch, Esther Oomen-de Hoop, Peter de Bruijn, Sander Bins, Eman Ibrahim, Suzan Nikkessen, Lena E. Friberg, Stijn L. W. Koolen, Manon C. W. Spaander, Ron H. J. Mathijssen
المصدر: Frontiers in Pharmacology, Vol 12 (2021)
مصطلحات موضوعية: tissue pharmacokinetics, intratumoral, paclitaxel, pharmacokinetics, esophageal cancer, ABCB1, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Tessa A. M. Mulder, Ruben A. G. van Eerden, Mirjam de With, Laure Elens, Dennis A. Hesselink, Maja Matic, Sander Bins, Ron H. J. Mathijssen, Ron H. N. van Schaik
المصدر: Frontiers in Genetics, Vol 12 (2021)
مصطلحات موضوعية: cytochrome P450, CYP3A4, CYP3A4∗22, genotyping, genotype-guided dosing, rs35599367, Genetics, QH426-470
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Florence Atrafi, Ruben A. G. van Eerden, Stijn L. W. Koolen, Peter de Bruijn, Cristianne J. F. Rijcken, Rob Hanssen, Ferry A. L. M. Eskens, Martijn P. Lolkema, Esther Oomen-de Hoop, Jeffrey Damman, Ron H. J. Mathijssen
المصدر: Cancers, Vol 13, Iss 15, p 3741 (2021)
مصطلحات موضوعية: nanoparticles, toxicity, docetaxel, pharmacokinetics, pharmacodynamics, chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Ruben A. G. van Eerden, Esther Oomen-de Hoop, Aad Noordam, Ron H. J. Mathijssen, Stijn L. W. Koolen
المصدر: Pharmaceuticals, Vol 14, Iss 2, p 119 (2021)
مصطلحات موضوعية: small molecule kinase inhibitor, trough level, Cmin, therapeutic drug monitoring, implementation, Medicine, Pharmacy and materia medica, RS1-441
وصف الملف: electronic resource
-
5
المؤلفون: Ron H.J. Mathijssen, Ruben A G van Eerden, Femke M. de Man, Gerdien M van Doorn, Joris N. Veraart, Henk K van Halteren, Yorick Sandberg, Esther Oomen-de Hoop, Ron W. F. de Bruin, Stijn L.W. Koolen, Teun van Gelder, Adriaan Moelker, Martijn E.T. Dollé, Jan N. M. IJzermans, Joanne F. Olieman, Peter de Bruijn, Martijn P. Lolkema
المساهمون: Medical Oncology, Internal Medicine, Pharmacy, Radiology & Nuclear Medicine, Surgery
المصدر: Clinical Pharmacology and Therapeutics, 109(5), 1304-1313. Wiley-Blackwell
مصطلحات موضوعية: Diarrhea, Male, medicine.medical_specialty, Neutropenia, Normal diet, Irinotecan, 030226 pharmacology & pharmacy, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, SDG 3 - Good Health and Well-being, intra-tumoral, Internal medicine, medicine, Diet, Protein-Restricted, Humans, Pharmacology (medical), protein and calorie restriction, Aged, Caloric Restriction, Pharmacology, business.industry, Liver Neoplasms, Area under the curve, Middle Aged, medicine.disease, 030220 oncology & carcinogenesis, Toxicity, Female, diet, business, pharmacokinetics, Febrile neutropenia, medicine.drug, Blood sampling
-
6
المؤلفون: Ron H.J. Mathijssen, Martijn P. Lolkema, Stijn L.W. Koolen, Ruben A G van Eerden, Cristianne J.F. Rijcken, Marte A.M. van Hylckama Vlieg, Alex Sparreboom, Ferry A.L.M. Eskens, Florence Atrafi, Esther Oomen-de Hoop, Rob Hanssen, Adriaan Moelker, Peter de Bruijn
المساهمون: Medical Oncology, Radiology & Nuclear Medicine
المصدر: Clinical Cancer Research, 26(14), 3537-3545. American Association for Cancer Research Inc.
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Neutropenia, Biopsy, Urology, 02 engineering and technology, Docetaxel, urologic and male genital diseases, Intratumoral chemotherapy, Metastatic lesion, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, SDG 3 - Good Health and Well-being, Neoplasms, medicine, Humans, In patient, Tissue Distribution, Infusions, Intravenous, neoplasms, Response Evaluation Criteria in Solid Tumors, Aged, Aged, 80 and over, Drug Carriers, Cross-Over Studies, Adult patients, business.industry, organic chemicals, Middle Aged, 021001 nanoscience & nanotechnology, Tumor tissue, Drug Liberation, Oncology, 030220 oncology & carcinogenesis, Nanoparticles, Female, Sampling time, 0210 nano-technology, business, therapeutics, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77ee1475ea1715c8d2117e42481df6b4
http://www.scopus.com/inward/record.url?scp=85087591926&partnerID=8YFLogxK -
7
المؤلفون: Ruben A G van Eerden, Cristianne J.F. Rijcken, Ferry A.L.M. Eskens, Stijn L.W. Koolen, Martijn P. Lolkema, Peter de Bruijn, Florence Atrafi, Rob Hanssen, Ron H.J. Mathijssen, Jeffrey Damman, Esther Oomen-de Hoop
المساهمون: Medical Oncology, Pharmacy, Pathology
المصدر: Cancers, Vol 13, Iss 3741, p 3741 (2021)
Cancers, 13(15):3741. Multidisciplinary Digital Publishing Institute (MDPI)
Cancersمصطلحات موضوعية: Cancer Research, medicine.medical_specialty, skin, medicine.medical_treatment, 02 engineering and technology, urologic and male genital diseases, chemotherapy, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, SDG 3 - Good Health and Well-being, Internal medicine, pharmacodynamics, Medicine, docetaxel, Nuclear atypia, neoplasms, RC254-282, Chemotherapy, integumentary system, business.industry, organic chemicals, Communication, toxicity, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 021001 nanoscience & nanotechnology, Skin toxicity, Oncology, Docetaxel, Apoptosis, 030220 oncology & carcinogenesis, Pharmacodynamics, Toxicity, nanoparticles, 0210 nano-technology, business, therapeutics, pharmacokinetics, medicine.drug
وصف الملف: application/pdf
-
8
المؤلفون: Stijn L.W. Koolen, Ron H.J. Mathijssen, Ruben A G van Eerden
المساهمون: Medical Oncology, Pharmacy
المصدر: International Journal of Nanomedicine
International Journal of Nanomedicine, 15, 8151-8166. Dove Medical Press Ltd.مصطلحات موضوعية: medicine.medical_specialty, Biophysics, Pharmaceutical Science, Bioengineering, Antineoplastic Agents, 02 engineering and technology, Review, 010402 general chemistry, 01 natural sciences, taxane, Biomaterials, drug delivery systems, SDG 3 - Good Health and Well-being, Neoplasms, Drug Discovery, medicine, Animals, Humans, cancer, Intensive care medicine, Adverse effect, Drug Carriers, Taxane, business.industry, nanoparticle, Organic Chemistry, Cancer, General Medicine, 021001 nanoscience & nanotechnology, medicine.disease, nanomedicine, 0104 chemical sciences, Review article, Nanostructures, Active compound, Drug delivery, Taxoids, 0210 nano-technology, business
وصف الملف: application/pdf
-
9
المؤلفون: Alwin D. R. Huitema, Stefanie L. Groenland, Jos H. Beijnen, Niels de Vries, Bas Thijssen, Hilde Rosing, Ruben A G van Eerden, Stijn L.W. Koolen, Remy B. Verheijen, Ron H.J. Mathijssen, Neeltje Steeghs
المساهمون: Medical Oncology, Pharmacy
المصدر: Clinical Pharmacokinetics, 59(7), 941-948. Adis
Clinical Pharmacokinetics, 59(7), 941. Adis International Ltdمصطلحات موضوعية: medicine.medical_specialty, Indazoles, medicine.drug_class, Urology, Cmax, 030226 pharmacology & pharmacy, Tyrosine-kinase inhibitor, Pazopanib, 03 medical and health sciences, Cmin, 0302 clinical medicine, Pharmacokinetics, SDG 3 - Good Health and Well-being, Interquartile range, medicine, Humans, Pharmacology (medical), Dosing, Prospective Studies, Carcinoma, Renal Cell, Pharmacology, Sulfonamides, business.industry, Kidney Neoplasms, Pyrimidines, Tolerability, 030220 oncology & carcinogenesis, business, medicine.drug
وصف الملف: application/pdf
-
10
المؤلفون: Remy B. Verheijen, Nielka P. van Erp, Stijn L.W. Koolen, Anna K.L. Reyners, Ruben A G van Eerden, Neeltje Steeghs, Ron H.J. Mathijssen, Ingrid M.E. Desar, Hans Gelderblom, Stefanie L. Groenland, Alwin D. R. Huitema, Dirk Jan A.R. Moes
المساهمون: Medical Oncology, Pharmacy, Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Therapeutic Drug Monitoring, 41(5), 561-567. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring, 41(5), 561-567. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, 41, 561-567
Therapeutic Drug Monitoring, 41(5), 561. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 41, 5, pp. 561-567مصطلحات موضوعية: PK, EXPOSURE-RESPONSE ANALYSIS, Administration, Oral, Medical Oncology, 030226 pharmacology & pharmacy, 0302 clinical medicine, RENAL-CELL CARCINOMA, Medicine, Drug Interactions, Pharmacology (medical), Prospective Studies, HUMAN PLASMA, Prospective cohort study, Non-U.S. Gov't, media_common, medicine.diagnostic_test, Research Support, Non-U.S. Gov't, personalized dosing, Treatment Outcome, PHASE-I, Tolerability, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Drug Monitoring, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Drug, medicine.medical_specialty, media_common.quotation_subject, oral anticancer drugs, Antineoplastic Agents, Research Support, IMATINIB, PAZOPANIB, TDM, 03 medical and health sciences, Cmin, Pharmacokinetics, individualized dosing, Journal Article, Humans, DOSE-ESCALATION, Dosing, TAMOXIFEN, Intensive care medicine, Pharmacology, business.industry, KINASE INHIBITORS, QUANTIFICATION, Therapeutic drug monitoring, Concomitant, business
وصف الملف: application/pdf; image/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcecc96f69f99850f826d4ac63c8ae88
https://hdl.handle.net/1887/122407